Performance of Endoscopic Ultrasound in the Diagnosis of Fatty Pancreas

Not Applicable

• Conditions: Diagnostic EUSFatty PancreasPancreatic cancer; Diagnostic EUS; Fatty Pancreas; Pancreatic cancer

• Registration Number: TCTR20200902004
• Lead Sponsor: Faculty of Medicine Siriraj Hospital, Mahidol University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-09-02
• Study Completion: 2021-09-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 108

Inclusion Criteria

Patient who scheduled pancreaticoduodenectomy or distal pancreatectomy in Siriraj hospital

Exclusion Criteria

1. Patient use drug induced visceral fatty accumulation such as amiodarone, steroid, methotrexate, sex hormone
2. Patient with high risk for EUS and surgery: bleeding tendency, unstable hemodynamics, severe cardiovascular disease

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diagnostic performance of EUS in fatty pancreas At the end of intervention Sensitivity, Specificity, PPV, NPV

Secondary Outcome Measures

Name	Time	Method
Predictive factors of fatty pancreas At the end of intervention Odd ratio, p-value,Association between fatty pancreas and pancreatic cancer At the end of intervention Odd ratio, p-value